Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection.

Drugs - 24 Dec 2012

Garnock-Jones Karly P

Abstract excerpt

Boceprevir (Victrelis®) is an inhibitor of the hepatitis C virus (HCV) non-structural protein NS3-4A serine protease and is used in combination with pegylated interferon (peginterferon)-alpha and ribavirin in the treatment of adults with chronic HCV (chronic hepatitis C) genotype 1 infection. Of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genotype
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proline

Share to Randomized Controlled Trials as Topic

Share to Treatment Outcome

Share to Viral Load

Source

Identifiers

PMID: 23231027
DOI: 10.2165/11209560-000000000-00000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23231027-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection.PMID 23231027Read ↗

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.Semantic proximity Read ↗

Boceprevir: a protease inhibitor for the treatment of hepatitis C.Semantic proximity Read ↗

Boceprevir: a recently approved protease inhibitor for hepatitis C virus infection.Semantic proximity Read ↗

Boceprevir for Chronic HCV Genotype 1 InfectionSemantic proximity Read ↗

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.Semantic proximity Read ↗

Boceprevir for previously treated chronic HCV genotype 1 infection.Semantic proximity Read ↗

Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionSemantic proximity Read ↗

Boceprevir in genotype 1 chronic hepatitis C: first experiences in Serbia.Semantic proximity Read ↗

Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.Semantic proximity Read ↗

[New agents for the treatment of hepatitis C].Semantic proximity Read ↗

7 BOCEPREVIR IN ADDITION TO STANDARD OF CARE ENHANCED SVR IN HEPATITIS C VIRUS (HCV) GENOTYPE-1 WITH ADVANCED FIBROSIS/CIRRHOSIS: SUBGROUP ANALYSIS OF SPRINT-2 AND RESPOND-2 STUDIESSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.